US Food and Drug Administration to set up new oncology office

被引：0

|

作者：

Tilstone, C

机构：

来源：

LANCET ONCOLOGY | 2004年 / 5卷 / 09期

关键词：

D O I：

10.1016/S1470-2045(04)01549-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：518 / 518

页数：1

相关论文

共 50 条

[31] Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020
Miljkovic, Milos D.
Tuia, Jordan E.
Olivier, Timothee
Haslam, Alyson
Prasad, Vinay
JAMA INTERNAL MEDICINE, 2022, 182 (12) : 1319 - 1320
[32] US Food and Drug Administration Approval of Flibanserin Even the Score Does Not Add Up
Woloshin, Steven
Schwartz, Lisa M.
JAMA INTERNAL MEDICINE, 2016, 176 (04) : 439 - 442
[33] Working to Advance Health Equity: The US Food and Drug Administration Office of Minority Health and Health Equity
Araojo, Richardae
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2021, 113 (03) : 359 - 362
[34] Surgical Innovation and the US Food and Drug Administration
Cundiff, Geoffrey W.
FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
[35] US Food and Drug Administration pushed to change
McCarthy, M
LANCET, 2006, 367 (9523): : 1643 - 1644
[36] Increasing Transparency at the US Food and Drug Administration
Steinbrook, Robert
JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1146 - 1147
[37] US Food and Drug Administration gets it right
Grove, ML
BRITISH MEDICAL JOURNAL, 2002, 325 (7367): : 776 - 776
[38] The US Food and Drug Administration and Emergency Contraception
Fox, Anthony W.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL MEDICINE, 2005, 19 (03): : 139 - 140
[39] Crisis deepens at the US Food and Drug Administration
Lenzer, J
BRITISH MEDICAL JOURNAL, 2004, 329 (7478): : 1308 - 1308
[40] Moving the US Food and Drug Administration Forward
Perlmutter, Joel S.
ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : 1626 - 1627

← 1 2 3 4 5 →